Matinas BioPharma Holdings, Inc. Balance Sheet
MTNB|10 years of annual SEC 10-K data (FY2015-FY2024)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 10 fiscal years. All figures from audited SEC 10-K filings.
Matinas BioPharma Holdings, Inc. had $13M in total assets and $8M in shareholders' equity as of FY2024.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7.3M | $6.8M | $21.0M | $21.0M | $12.4M | $22.2M | $7.3M | $4.1M | $4.1M | $3.2M |
| Current Assets | $8.0M | $15.5M | $34.5M | $51.0M | $61.6M | $29.9M | $13.1M | $8.0M | $4.6M | $3.6M |
| PP&E (Net) | $468.0K | $1.9M | $2.1M | $1.5M | $1.5M | $1.7M | $2.0M | $1.6M | $356.1K | $377.7K |
| Goodwill | - | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M |
| Total Assets | $12.6M | $25.1M | $44.8M | $61.3M | $71.0M | $40.2M | $19.9M | $14.4M | $9.8M | $8.4M |
| Current Liabilities | $2.7M | $2.6M | $4.3M | $4.3M | $3.6M | $3.1M | $2.8M | $2.2M | $1.4M | $1.1M |
| Shareholders' Equity | $7.6M | $36.6M | $52.5M | $52.5M | $63.7M | $16.1M | $10.7M | $7.1M | $7.1M | $6.1M |